Xenotransplantation: Where are we in 2008?

Kidney International

Volumn 74, Issue 1, 2008, Pages 14-21

  Sprangers, B ^a,b   Waer, M ^a   Billiau, A D ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Acute humoral rejection; Hyperacute rejection; Infection; Pig; Transgenic; Xenotransplantation

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; CHIMERIC ANTIBODY;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; CHIMERA; CONTROLLED STUDY; GRAFT REJECTION; HUMORAL IMMUNITY; IMMUNOBIOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE ACTIVATION; NATURAL KILLER CELL; NONHUMAN; ORGAN DONOR; PRIMATE; PRIORITY JOURNAL; SHORT SURVEY; SURVIVAL TIME; SWINE; XENOTRANSPLANTATION;

EID: 45249088523     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.135     Document Type: Short Survey

References (64)

1. Andreoni KA, Brayman KL, Guidinger MK et al. Kidney and pancreas transplantation in the United States, 1996-2005. Am J Transplant 2007; 7: 1359-1375.
2. UNOS. United Network for Organ Sharing: Richmond, VA. Available at http://www.unos.org.
3. Eurotransplant International Foundation. Leiden, The Netherlands. Available at http://www.transplant.org.
4. Lin SS, Weidner BC, Byrne GW et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998; 101: 1745-1756.
5. Kobayashi T, Taniguchi S, Neethling FA et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 1997; 64: 1255-1261.
6. Schuurman HJ, Pino-Chavez G, Phillips MJ et al. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors. Transplantation 2002; 73: 1146-1151.
7. Diamond LE, Quinn CM, Martin MJ et al. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 2001; 71: 132-142.
8. Niemann H, Verhoeyen E, Wonigeit K et al. Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection. Transplantation 2001; 72: 1898-1906.
9. Lai L, Kolber-Simonds D, Park KW et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089-1092.
10. Schuurman HJ, Cheng J, Lam T. Pathology of xenograft rejection: a commentary. Xenotransplantation 2003; 10: 293-299.
11. Yamada K, Yazawa K, Shimizu A et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005; 11: 32-34.
12. Kuwaki K, Tseng YL, Dor FJ et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29-31.
13. Chen G, Qian H, Starzl T et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005; 11: 1295-1298.
14. Jin R, Greenwald A, Peterson MD et al. Human monocytes recognize porcine endothelium via the interaction of galectin 3 and alpha-GAL. J Immunol 2006; 177: 1289-1295.
15. Lilienfeld BG, Crew MD, Forte P et al. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Xenotransplantation 2007; 14: 126-134.
16. Lilienfeld BG, Garcia-Borges C, Crew MD et al. Porcine UL16-binding protein 1 expressed on the surface of endothelial cells triggers human NK cytotoxicity through NKG2D. J Immunol 2006; 177: 2146-2152.
17. Wang H, VerHalen J, Madariaga ML et al. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47. Blood 2007; 109: 836-842.
18. Dwyer KM, Robson SC, Nandurkar HH et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 2004; 113: 1440-1446.
19. Sykes M, Shimizu I, Kawahara T. Mixed hematopoietic chimerism for the simultaneous induction of T and B cell tolerance. Transplantation 2005; 79: S28-S29.
20. Kawahara T, Rodriguez-Barbosa JI, Zhao Y et al. Global unresponsiveness as a mechanism of natural killer cell tolerance in mixed xenogeneic chimeras. Am J Transplant 2007; 7: 2090-2097.
21. Yamada K, Shimizu A, Ierino FL et al. Thymic transplantation in miniature swine. I. Development and function of the 'thymokidney'. Transplantation 1999; 68: 1684-1692.
22. Yamada K, Shimizu A, Utsugi R et al. Thymic transplantation in miniature swine. II. Induction of tolerance by transplantation of composite thymokidneys to thymectomized recipients. J Immunol 2000; 164: 3079-3086.
23. Yang YG, Sykes M. Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol 2007; 7: 519-531.
24. Dwyer KM, Cowan PJ, d'Apice AJ. Xenotransplantation: past achievements and future promise. Heart Lung Circ 2002; 11: 32-41.
25. McGregor CG, Teotia SS, Byrne GW et al. Cardiac xenotransplantation: progress toward the clinic. Transplantation 2004; 78: 1569-1575.
26. McGregor CG, Davies WR, Oi K et al. Cardiac xenotransplantation: recent preclinical progress with 3-month median survival. J Thorac Cardiovasc Surg 2005; 130: 844-851.
27. Cascalho M, Platt JL. The immunological barrier to xenotransplantation. Immunity 2001; 14: 437-446.
28. Davila E, Byrne GW, LaBreche PT et al. T-cell responses during pig-to-primate xenotransplantation. Xenotransplantation 2006; 13: 31-40.
29. Cardona K, Korbutt GS, Milas Z et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12: 304-306.
30. Hering BJ, Wijkstrom M, Graham ML et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006; 12: 301-303.
31. Ohdan H, Swenson KG, Kruger Gray HS et al. Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Gal alpha 1,3Gal epitopes in alpha 1,3-galactosyltransferase-deficient mice. J Immunol 2000; 165: 5518-5529.
32. Li S, Yan Y, Lin Y et al. Rapidly induced, T-cell independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells. Blood 2007; 110: 3926-3935.
33. Murray AG, Khodadoust MM, Pober JS et al. Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1: 57-63.
34. Yamada K, Sachs DH, DerSimonian H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 1995; 155: 5249-5256.
35. Porter CM, Bloom ET. Human CD4+CD25+ regulatory T cells suppress anti-porcine xenogeneic responses. Am J Transplant 2005; 5: 2052-2057.
36. Kuwaki K, Knosalla C, Dor FJ et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen. Am J Transplant 2004; 4: 363-372.
37. Yamamoto S, Lavelle JM, Vagefi PA et al. Vascularized thymic lobe transplantation in a pig-to-baboon model: a novel strategy for xenogeneic tolerance induction and T-cell reconstitution. Transplantation 2005; 80: 1783-1790.
38. Fudaba Y, Spitzer TR, Shaffer J et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant 2006; 6: 2121-2133.
39. Ohdan H, Yang YG, Swenson KG et al. T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3- galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Transplantation 2001; 71: 1532-1542.
40. Tseng YL, Sachs DH, Cooper DK. Porcine hematopoietic progenitor cell transplantation in nonhuman primates: a review of progress. Transplantation 2005; 79: 1-9.
41. Lan P, Wang L, Diouf B et al. Induction of human T-cell tolerance to porcine xenoantigens through mixed hematopoietic chimerism. Blood 2004; 103: 3964-3969.
42. Itescu S, Kwiatkowski P, Artrip JH et al. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Hum Immunol 1998; 59: 275-286.
43. Candinas D, Belliveau S, Koyamada N et al. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. Transplantation 1996; 62: 1920-1927.
44. Forte P, Lilienfeld BG, Baumann BC et al. Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D. J Immunol 2005; 175: 5463-5470.
45. Lin Y, Vandeputte M, Waer M. Contribution of activated macrophages to the process of delayed xenograft rejection. Transplantation 1997; 64: 1677-1683.
46. Wallgren AC, Karlsson-Parra A, Korsgren O. The main infiltrating cell in xenograft rejection is a CD4+ macrophage and not a T lymphocyte. Transplantation 1995; 60: 594-601.
47. Yi S, Hawthorne WJ, Lehnert AM et al. T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 2003; 170: 2750-2758.
48. Oldenborg PA, Zheleznyak A, Fang YF et al. Role of CD47 as a marker of self on red blood cells. Science 2000; 288: 2051-2054.
49. Ide K, Wang H, Tahara H et al. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci USA 2007; 20: 5062-5066.
50. Cowan PJ. Coagulation and the xenograft endothelium. Xenotransplantation 2007; 14: 7-12.
51. Shrivastava S, McVey JH, Dorling A. The interface between coagulation and immunity. Am J Transplant 2007; 7: 499-506.
52. Byrne GW, Schirmer JM, Fass DN et al. Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. Am J Transplant 2005; 5: 1011-1020.
53. Byrne GW, Davies WR, Oi K et al. Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival. Transplantation 2006; 82: 1787-1791.
54. Chen D, Weber M, McVey JH et al. Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium. Am J Transplant 2004; 4: 1958-1963.
55. Dwyer KM, Mysore TB, Crikis S et al. The transgenic expression of human CD39 on murine islets inhibits clotting of human blood. Transplantation 2006; 82: 428-432.
56. d'Apice AJ. Is xenotransplantation of vascularized organs just too hard? Xenotransplantation 2006; 13: 182-185.
57. Ibrahim Z, Busch J, Awwad M et al. Selected physiologic compatibilities and incompatibilities between human and porcine organ systems. Xenotransplantation 2006; 13: 488-499.
58. Bach FH, Fishman JA, Daniels N et al. Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat Med 1998; 4: 141-144.
59. Fishman JA, Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant 2004; 4: 1383-1390.
60. Oldmixon BA, Wood JC, Ericsson TA et al. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol 2002; 76: 3045-3048.
61. Sykes M, D'Apice A, Sandrin M. Position paper of the Ethics Committee of the International Xenotransplantation Association. Transplantation 2004; 78: 1101-1107.
62. Cardona K, Milas Z, Strobert E et al. Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant 2007; 7: 2260-2268.
63. Buhler L, Sgroi A, Sykes M et al. International inventory of xenotransplantation practices in humans. Xenotransplantation 2006; 13: 482.
64. Sykes M. Commentary: World Health Assembly resolution 57.18 on xenotransplantation. Transplantation 2005; 79: 636-637.